(Q43720859)

26 November 2017

title

When should triptans be taken during a migraine attack? (English)

1 reference

26 November 2017

1 reference

J Schoenen

1

1 reference

26 November 2017

publication date

1 January 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

15

1 reference

26 November 2017

issue

8

1 reference

26 November 2017

page(s)

583-587

1 reference

A randomized, double-blind comparison of sumatriptan and Cafergot in the acute treatment of migraine. The Multinational Oral Sumatriptan and Cafergot Comparative Study Group

26 November 2017

cites work

1 reference

12 December 2020

2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study

1 reference

12 December 2020

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

1 reference

12 December 2020

A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group

1 reference

12 December 2020

Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan

1 reference

12 December 2020

Sumatriptan in clinical practice: a 2-year review of 453 migraine patients

1 reference

12 December 2020

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

1 reference

12 December 2020

Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence

1 reference

12 December 2020

The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group

1 reference

12 December 2020

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

1 reference

12 December 2020

An association between migraine and cutaneous allodynia.

1 reference

12 December 2020

Sumatriptan in the Treatment of Acute Migraine With Aura

1 reference

12 December 2020

Methodology of clinical trials of sumatriptan in migraine and cluster headache

1 reference

12 December 2020

Treatment of Mild Headache in Disabled Migraine Sufferers: Results of the Spectrum Study

1 reference

12 December 2020

Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo.

1 reference

12 December 2020

Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data

1 reference

12 December 2020

10.2165/00023210-200115080-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

26 November 2017

1006973179

0 references

1 reference